Inam Butt and a Reduced Doping Sanction: Why Medical Paperwork Could Not Save the Silver

The season's decisive fall did not come from a wrestling hold. It came from a small bottle of eye medicine. Last April, at the Asian beach wrestling event, Inam Butt — a former beach wrestling world champion from Pakistan — collected a silver medal. Weeks later, his sample landed in a file handled by the International Testing Agency (ITA).

According to Pakistani press reports, the ITA accepted that the detected substance was medication for an eye condition, not a performance-enhancing drug. What remained was a purely procedural fault: Butt did not complete a Therapeutic Use Exemption (TUE) in time. The expected sanction is roughly two months, backdated to April, along with forfeiture of the silver medal.

This is the kind of file I read slowly, because most of its value sits in the lines that were never written. When I mispronounce a wrestler's name, I learn to listen to the file before explaining it.

Beach wrestling is a young discipline compared with freestyle and Greco-Roman within the United World Wrestling (UWW) system. The field is narrower, the athlete pool smaller, and a world title here carries real weight even though the competitive pyramid is lower than a traditional Olympic-category title. That determines who protects whom when something goes wrong.

Inam Butt is not only a wrestler. He is simultaneously a national squad coach, secretary of the Pakistan Wrestling Federation (PWF), and chairman of the Pakistan Olympic Association (POA) athletes commission. Four roles in one person. When the doping file opened, he was the one who voluntarily stepped down from two administrative posts, citing the need to protect the impartiality of the investigation. That detail drew little media attention, yet it is the most valuable fact in the whole sequence.

Every doping case contains two parallel battles. The first is scientific: what the substance is, and whether it enhances performance. The second is documentary: whether the athlete declared, applied and filed everything correctly.

In Butt's case, the first battle ended in his favour. The ITA accepted the medical basis. The second battle is where he lost. An athlete's mistake sometimes lies not in taking a banned substance, but in letting their medical paperwork lag one step behind the testing authority.

Three scenarios can be built from the available facts. Worst case: the ITA treats the late TUE as ordinary negligence, producing a suspension of months to years, loss of the medal and lasting reputational damage. Base case: a short suspension of about two months, backdated to April, forfeiture of the silver, and Asian Games eligibility preserved. Best case: a reprimand only, if the ITA fully credits the medical basis and the one-year permission already granted.

The crux is this: medal forfeiture is a consequence of strict liability, largely independent of a finding that the use was therapeutic. Even when the suspension is reduced, the record stays marked. That is the boundary the media often blurs when it chooses the headline of good news for the athlete.

One detail needs cross-checking: the report says Butt failed to obtain the TUE in time, yet also says the ITA permitted that medication for a one-year period. The two only reconcile if the exemption was granted retroactively, or covered a different window. There is no clear answer in the available sources, so I keep my judgement at medium confidence.

There is a reading few people choose. The case is not about a cheat who was caught, nor about an innocent man wronged. It is about the gap between medicine and administration — two things an athlete must manage at once, while each runs on its own clock.

The body needs the drug now. The governing body needs the paperwork first. When the two clocks diverge, the athlete pays, regardless of whether the doctor prescribed correctly.

Seen more broadly, the Butt case exposes a structural weakness of small federations: a thin talent pool forces one individual to compete, coach and administer at the same time. That concentration of roles is convenient day to day, but turns any complaint into a conflict-of-interest problem. When the person under investigation also sits inside the decision-making body, the legitimacy of the whole system comes into question.

Every situation on the mat is a hypothesis, and I am the type who likes to verify. Here, the hypothesis most worth testing is not whether he cheated, but how many other athletes sit in exactly this position with no one to ask.

Across more than two decades of watching regional and international wrestling, I see one recurring pattern: athletes in small federations tend to be better at enduring than at paperwork. They are taught how to take pain, how to lock a hold, how to recover — but rarely how to manage a medical file that can decide a career.

Data points to talent, but the heart points to the champion. Paperwork points to who is allowed to keep competing. Those three do not substitute for one another.

The ITA's formal decision is expected within a week. If it lands as reported, Inam Butt returns to the mat. But the silver medal from April has already stayed behind.